Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $572000.0.

  • Mimedx's Depreciation and Depletion fell 137.93% to $572000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 143.04%. This contributed to the annual value of $2.3 million for FY2024, which is 1448.41% down from last year.
  • As of Q3 2025, Mimedx's Depreciation and Depletion stood at $572000.0, which was down 137.93% from $558000.0 recorded in Q2 2025.
  • In the past 5 years, Mimedx's Depreciation and Depletion ranged from a high of $1.3 million in Q2 2021 and a low of $558000.0 during Q1 2024
  • In the last 5 years, Mimedx's Depreciation and Depletion had a median value of $700500.0 in 2023 and averaged $764611.1.
  • In the last 5 years, Mimedx's Depreciation and Depletion plummeted by 4106.0% in 2021 and then changed by 0.0% in 2025.
  • Quarter analysis of 5 years shows Mimedx's Depreciation and Depletion stood at $973000.0 in 2021, then decreased by 18.19% to $796000.0 in 2022, then decreased by 23.24% to $611000.0 in 2023, then fell by 7.69% to $564000.0 in 2024, then increased by 1.42% to $572000.0 in 2025.
  • Its Depreciation and Depletion stands at $572000.0 for Q3 2025, versus $558000.0 for Q2 2025 and $564000.0 for Q4 2024.